These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
350 related articles for article (PubMed ID: 35047242)
41. Risk Factors for Adolescent Cannabis Use in a State With Legal Recreational Cannabis: The Role of Parents, Siblings, and Friends. English F; Whitehill JM Clin Ther; 2023 Jun; 45(6):589-598. PubMed ID: 37414509 [TBL] [Abstract][Full Text] [Related]
42. Nine Insights From 10 Years of Legal Cannabis for Nonmedical Purposes. Kilmer B; Pérez-Dávila S Clin Ther; 2023 Jun; 45(6):496-505. PubMed ID: 37414499 [TBL] [Abstract][Full Text] [Related]
43. Indications and administration practices amongst medical cannabis healthcare providers: a cross-sectional survey. Corroon J; Sexton M; Bradley R BMC Fam Pract; 2019 Dec; 20(1):174. PubMed ID: 31837706 [TBL] [Abstract][Full Text] [Related]
44. Out-of-state cannabis purchases in the United States. Wadsworth E; Hammond D Drug Alcohol Depend; 2020 Feb; 207():107822. PubMed ID: 31911336 [TBL] [Abstract][Full Text] [Related]
45. Impact of state-level cannabis legalization on poly use of alcohol and cannabis in the United States, 2004-2017. Kim JH; Weinberger AH; Zhu J; Barrington-Trimis J; Wyka K; Goodwin RD Drug Alcohol Depend; 2021 Jan; 218():108364. PubMed ID: 33143941 [TBL] [Abstract][Full Text] [Related]
46. The relationship between cannabis use and legalization frameworks: A cross-sectional analysis using a nationally representative survey. Vachhani K; Wijeysundera DN; Mistry N; Clarke H; Diep C; Ladha KS Prev Med; 2022 Mar; 156():106978. PubMed ID: 35131207 [TBL] [Abstract][Full Text] [Related]
47. Public Health Implications of Cannabis Legalization: An Exploration of Adolescent Use and Evidence-Based Interventions. Donnelly J; Young M; Marshall B; Hecht ML; Saldutti E Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329023 [TBL] [Abstract][Full Text] [Related]
48. Survey of Patients Employing Cannabigerol-Predominant Cannabis Preparations: Perceived Medical Effects, Adverse Events, and Withdrawal Symptoms. Russo EB; Cuttler C; Cooper ZD; Stueber A; Whiteley VL; Sexton M Cannabis Cannabinoid Res; 2022 Oct; 7(5):706-716. PubMed ID: 34569849 [No Abstract] [Full Text] [Related]
49. Trends in the use of cannabis products in Canada and the USA, 2018 - 2020: Findings from the International Cannabis Policy Study. Hammond D; Goodman S; Wadsworth E; Freeman TP; Kilmer B; Schauer G; Pacula RL; Hall W Int J Drug Policy; 2022 Jul; 105():103716. PubMed ID: 35613480 [TBL] [Abstract][Full Text] [Related]
50. Association Between Markers of Vulnerability for Cannabis-Related Harms and Source of Supply: Secondary Analysis of a Representative Population Survey. Drouin S; Rizkallah É; Conus F; Larney S; Kaur N; Djignefa Djade C; Jutras-Aswad D Can J Psychiatry; 2023 Feb; 68(2):109-118. PubMed ID: 36168206 [TBL] [Abstract][Full Text] [Related]
51. Illicit Cannabis Use to Self-Treat Chronic Health Conditions in the United Kingdom: Cross-Sectional Study. Erridge S; Troup L; Sodergren MH JMIR Public Health Surveill; 2024 Aug; 10():e57595. PubMed ID: 39149844 [TBL] [Abstract][Full Text] [Related]
52. Clinician Beliefs and Practices Related to Cannabis. Schauer GL; Njai R; Grant AM Cannabis Cannabinoid Res; 2022 Aug; 7(4):508-515. PubMed ID: 33998899 [No Abstract] [Full Text] [Related]
53. Attitudes about and correlates of cannabis legalization policy among U.S. young adults. Rudy AK; Barnes AJ; Cobb CO; Nicksic NE J Am Coll Health; 2021; 69(8):889-896. PubMed ID: 31995455 [TBL] [Abstract][Full Text] [Related]
54. Prevalence and forms of cannabis use in legal vs. illegal recreational cannabis markets. Goodman S; Wadsworth E; Leos-Toro C; Hammond D; Int J Drug Policy; 2020 Feb; 76():102658. PubMed ID: 31927413 [TBL] [Abstract][Full Text] [Related]
55. Patterns of cannabis use, perception of harm, and perceived impact of legislative change in an online sample of young adults from Lebanon: insight on recreational users versus dual motive users. Ghandour L; Slim A; Abbas N; El-Khoury J Harm Reduct J; 2024 Feb; 21(1):41. PubMed ID: 38360652 [TBL] [Abstract][Full Text] [Related]
56. Medical Cannabis in Serbia: The Survey of Knowledge and Attitudes in an Urban Adult Population. Gazibara T; Prpic M; Maric G; Pekmezovic T; Kisic-Tepavcevic D J Psychoactive Drugs; 2017; 49(3):217-224. PubMed ID: 28632077 [TBL] [Abstract][Full Text] [Related]
57. Youth cannabis use in Canada post-legalization: service providers' perceptions, practices, and recommendations. Kourgiantakis T; Lee E; Kosar AKT; Tait C; Lau CKY; McNeil S; Craig S; Ashcroft R; Williams CC; Goldstein AL; Chandrasekera U; Sur D; Henderson JL Subst Abuse Treat Prev Policy; 2023 Jun; 18(1):36. PubMed ID: 37349741 [TBL] [Abstract][Full Text] [Related]
58. Cannabis consumers' preferences for legal and illegal cannabis: evidence from a discrete choice experiment. Xing J; Shi Y BMC Public Health; 2024 Sep; 24(1):2397. PubMed ID: 39227852 [TBL] [Abstract][Full Text] [Related]
59. Cannabis Policy and Consumption: Taking into account Substitution Effects. Wilds KM; Riddell JR Subst Use Misuse; 2024; 59(1):97-109. PubMed ID: 37781770 [No Abstract] [Full Text] [Related]
60. Reasons for Purchasing Cannabis From Illegal Sources in Legal Markets: Findings Among Cannabis Consumers in Canada and U.S. States, 2019-2020. Goodman S; Wadsworth E; Hammond D J Stud Alcohol Drugs; 2022 May; 83(3):392-401. PubMed ID: 35590180 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]